Citation Impact

Citing Papers

Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Distinct Profiles of Gastritis in Dyspepsia Subgroups: Their Different Clinical Responses to Gastritis Healing afterHelicobacter pyloriEradication
1994
Hepatocellular carcinoma
2003 Standout
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Classification and Grading of Gastritis
1996 Standout
The toxicology of aflatoxins as a basis for public health decisions
2002
Molecular pathogenesis of human hepatocellular carcinoma
2002
Functional Gastroduodenal Disorders
2006 Standout
Sphingolipids and their metabolism in physiology and disease
2017 Standout
The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country
2001
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Chronic kidney disease alters intestinal microbial flora
2012 Standout
In vitro Pharmacological Characterization of Mitemcinal (GM-611), the First Acid-Resistant Non-Peptide Motilin Receptor Agonist, in Smooth Muscle of Rabbit Small Intestine
2006 StandoutNobel
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia
2005
The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection
2009
Irritable bowel syndrome
2016 Standout
ORAL MITEMCINAL (GM‐611), AN ERYTHROMYCIN‐DERIVED PROKINETIC, ACCELERATES NORMAL AND EXPERIMENTALLY DELAYED GASTRIC EMPTYING IN CONSCIOUS DOGS
2007 StandoutNobel
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations
2008 StandoutNobel
Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis
1996
Racial differences in Helicobacter pylori seroprevalence in Singapore: Correlation with differences in peptic ulcer frequency
1997
Drug Insight: gastrointestinal stromal tumors (GIST)—the solid tumor model for cancer-specific treatment
2008
Effects of Mitemcinal (GM-611), an Acid-Resistant Nonpeptide Motilin Receptor Agonist, on the Gastrointestinal Contractile Activity in Conscious Dogs
2007 StandoutNobel
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1
2000
What Role Does Helicobacter pylori Play in Dyspepsia and Nonulcer Dyspepsia? Arguments For and Against H. pylori Being Associated With Dyspeptic Symptoms
1997
Basic and clinical aspects of visceral hyperalgesia
1994
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
2007 Standout
The gastrointestinal tract in uremia
1993
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
1998
MITEMCINAL (GM‐611), AN ORALLY ACTIVE MOTILIN RECEPTOR AGONIST, IMPROVES DELAYED GASTRIC EMPTYING IN A CANINE MODEL OF DIABETIC GASTROPARESIS
2008 StandoutNobel
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Review article: functional dyspepsia—should treatment be targeted on disturbed physiology?
1995
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Mycotoxins and human disease: a largely ignored global health issue
2009 Standout
Helicobacter pyloriInfection
2002 Standout
树鼩——作为一种新颖的非人灵长类实验疾病动物模型
2017 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
AGA technical review on irritable bowel syndrome
2002 Standout
Organ‐specific profiles of genetic changes in cancers caused by activation‐induced cytidine deaminase expression
2008 StandoutNobel
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
INFECTIONS ASSOCIATED WITH UREMIA AND DIALYSIS
2001
The cancer genome
2009 StandoutNature
Sphingosine Kinase 1 Promotes Malignant Progression in Colon Cancer and Independently Predicts Survival of Patients With Colon Cancer by Competing Risk Approach in South Asian Population
2014
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
2019 Standout
Candida Infections of Medical Devices
2004 Standout
THE ROLE OF HELICOBACTER PYLORI IN NONULCER DYSPEPSIA
1993
The role of Helicobacter pylori in nonulcer dyspepsia. A debate--for.
1993
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human
2017
Eradication of Helicobacter pylori for non-ulcer dyspepsia
2011
Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology
2005 Standout
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout

Works of A Wee being referenced

Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore.
1990
Gastroduodenal mucosa in uraemia: endoscopic and histological correlation and prevalence of helicobacter-like organisms.
1990
Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore
1995
Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours
2007
Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study.
1990
Differential MicroRNA Expression Profile in Myxomatous Mitral Valve Prolapse and Fibroelastic Deficiency Valves
2016
Rankless by CCL
2026